The UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI) is pleased to present the inaugural Innovations in Regulatory Science Summit, a gathering of leaders from academia, industry and regulatory agencies to discuss the role of regulatory science in medical product development. This event will comprise primarily of panel discussions and short research talks by CERSI investigators on ongoing collaborative research projects with FDA investigators. The panel discussions will focus on the following topics:
Artificial intelligence, Deep Learning and Novel Statistical Approaches: Is There a New Future for Clinical Development?
Model-informed, Adaptive Clinical Trials to Accelerate Development and Evaluation of Next Generation Drugs and Biologics
Accelerating the Approval of Innovative Devices to Mitigate Investment Risk
The Evolving Regulatory Science of Digital Health
Patient Participation and Real-World Evidence to Guide Regulatory Science
Expertise vs Perceived Conflict of Interest: Best Practices for Physicians and Scientists to Advise Regulatory Agencies
The Role of Academia, Government and Industry in Regulatory Science: New models for Cross-Sector Collaboration
Advancing Discovery to First-In-Human Clinical Trials for New Medical Products
More information is available at
https://www.ucsfstanfordcersi.org/jpmorgan2019.